Phase III Study of Interferon Alfa-NL as Adjuvant Treatment for Resectable Renal Cell Carcinoma: An Eastern Cooperative Oncology Group/Intergroup Trial
- 1 April 2003
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (7) , 1214-1222
- https://doi.org/10.1200/jco.2003.02.005
Abstract
Purpose: To evaluate the role of adjuvant interferon alfa after complete resection of locally extensive renal cell carcinoma. Patients and Methods: A total of 283 eligible patients with pT3–4a and/...Keywords
This publication has 36 references indexed in Scilit:
- Phase III Trial of Interferon Alfa-2a With or Without 13-cis-Retinoic Acid for Patients With Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 2000
- Interferon Gamma-1b Compared with Placebo in Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 1998
- Natural history and therapy of metastatic renal cell carcinomaCancer, 1997
- Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy.Journal of Clinical Oncology, 1994
- IMMUNOTHERAPY FOR METASTATIC RENAL CELL CARCINOMAUrologic Clinics of North America, 1993
- An Assessment of the Current Use of Human Interferons in Therapy of Urological CancersJournal of Urology, 1989
- Phase I/II Study of Recombinant Interferon Gamma in Advanced Renal Cell CarcinomaJournal of Urology, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Renal cell carcinoma: Survival and prognostic factorsUrology, 1986
- The Results of Radical Nephrectomy for Renal Cell CarcinomaJournal of Urology, 1969